F2G license Cresset’s Forge to complement successful consulting projects

Cambridge, UK – 8th April 2015 – Cresset, innovative provider of computational chemistry software and services, is pleased to announce that F2G, a UK biotech focusing on the discovery and development of novel compounds to treat life threatening fungal diseases, has chosen to license Cresset’s Forge software to help them develop the next generation of…

Read More…

ACS Denver 2015: Alignment of diverse ligands for a protein: a solved problem?

There are many methods available to align ligands in 3D in the absence of protein information. However, they fall into three main classes: atom matching/pharmacophore-based methods (GALAHAD, Open3DALIGN, Align-it), shape/electrostatics-based methods (Cresset, ROCS, Phase Shape, ShaEP) and QM potential-derived methods (CosmoSim3D). Each of these methods has different strengths and weaknesses. We have tested representatives of…

Read More…

ACS Denver 2015: Scaffold hopping: Balancing novelty, accessibility and physico-chemical properties

Scaffold hopping remains a central task in medicinal chemistry for generating and protecting intellectual property. We have previously presented a technique for rapidly generating reasonable yet novel scaffold replacements using molecular fields which has been extended to include R-group replacement. The approach uses a database of molecule fragments or available reagents to suggest replacements that…

Read More…

March 2015 newsletter

A 3D-QSAR study on DPP-4 inhibitors In this case study, Giovanna Tedesco describes how a robust 3D-QSAR (Quantitative Structure Activity Relationship) model was built for a data set of 73 dipeptidyl peptidase IV (DPP-4, a serine protease) inhibitors using Forge, Cresset’s powerful ligand-focused workbench for understanding SAR and design. Ad hoc Forge 3D display capabilities…

Read More…

Using Cresset’s Spark to grow and link distant fragment hits with sensible chemistry

Abstract The main advantage of fragment-based drug discovery (FBDD) is that the starting point, despite having weak potency, often has high efficiency of interaction with biological target. Optimization of the fragment by adding atoms ideally preserves this initial efficiency, to yield a tractable lead with superior properties. One potential pitfall is that modern hit optimization…

Read More…